Cancer

Accord’s biosimilar Pelgraz poised for approval

Cancer biosimilar drug Pelgraz is poised to hit the market after receiving a positive opinion by the Committee for Medicinal Products for Human Use (CHMP).

News

KEYTRUDA is a prescription medicine used to treat a kind of skin cancer called melanoma

Keytruda 100mg/4mL Vial and Carton
2015

EU regulators reject new use for Opdivo, as Keytruda edges a...

Keytruda begins to win battle of the immunotherapies

News

Celgene plans filing for Revlimid/rituximab in lymphoma

Filings planned in early 2019

News

FDA approves second Neupogen biosimilar

Already facing competition from Sandoz, Amgen’s Neupogen white blood cell stimulator faces another cut-price near-copy after the FDA approved Pfizer’s biosimilar, Nivestym.

News

Tablets on dollar bills (treatment, addiction, aging - concept). Vintage effect.

China strives to lower cost of cancer drugs as disease rates...

China is pushing domestic and overseas markets to lower the cost of cancer drugs to make them more accessible.

News

AbbVie raises hopes for blood cancer patients

AbbVie has filed its Venclexta (venetoclax) for a new use that it hopes could change the treatment of one of the most aggressive cancers – acute myeloid leukaemia (AML).

Accord’s biosimilar Pelgraz poised for approval

EU regulators reject new use for Opdivo, as Keytruda edges a...

Celgene plans filing for Revlimid/rituximab in lymphoma

FDA approves second Neupogen biosimilar

China strives to lower cost of cancer drugs as disease rates...

AbbVie raises hopes for blood cancer patients

CEPI steps in to fund Moderna's pandemic flu jab

How to meet your physicians where they are online

Cancer

Editor's Picks